AK Medical Oy is a limited company based in Tampere, registered in 2019. In the financial year ending 31.10.2025, revenue was 296 t€ and operating profit 55 t€; equity ratio 95.3 %. Its taxable income in 2024 was 105 t€ and its income taxes 21 t€.
Revenue 2025296 t€-20 % on the previous year
Operating profit55 t€18,7 % of revenue
Net profit44 t€EBITDA 55 t€
Equity ratio95,3 %quick ratio 4,48
Taxable income 2024105 t€
upper half of its industry
Income taxes 202421 t€72 t€ in 2020–2024
In business7 yrsregistered 4.10.2019
Tampere: 53 new companies in 30 days
- Puhakka Consulting OyRakennuttaminen ja rakennushankkeiden kehittäminen
- Markus Vallinoja Holding OyHoldingyhtiöiden toiminta
- Metsuripalvelu Mähönen OyMetsätaloutta palveleva toiminta
Try for free
Get your area's new companies by email every morning. 14 days, no card needed.
Financials
RevenueOperating profitNet profit
| Key figures | 31.10.2025 | 31.10.2024 | 31.10.2023 |
|---|---|---|---|
| Revenue | 296 t€ | 367 t€ | 304 t€ |
| Revenue change | -19,5 % | 20,9 % | – |
| EBITDA | 55 t€ | 105 t€ | 73 t€ |
| EBITDA % | 18,7 % | 28,6 % | 24,1 % |
| Operating profit | 55 t€ | 105 t€ | 73 t€ |
| Operating margin | 18,7 % | 28,6 % | 24,1 % |
| Net profit | 44 t€ | 84 t€ | 60 t€ |
| Personnel costs | -127 t€ | 159 t€ | 134 t€ |
| Equity ratio | 95,3 % | 90,1 % | 88,5 % |
| Quick ratio | 4,48 | 2,85 | 3,30 |
| Current ratio | 4,48 | 2,85 | 3,30 |
| Debt to revenue | 4,6 % | 7,5 % | 7,7 % |
| Return on equity | 16,0 % | 33,5 % | 33,3 % |
| Balance sheet total | 287 t€ | 278 t€ | 204 t€ |
| Equity | 274 t€ | 250 t€ | 181 t€ |
| Cash and bank | 27 t€ | 14 t€ | 29 t€ |
Balance sheet
Balance sheet totalEquityCash
Income statement and balance sheet
Income statement
| 31.10.2025 | 31.10.2024 | 31.10.2023 | |
|---|---|---|---|
| Turnover | 296 t€ | 367 t€ | 304 t€ |
| Other operating income | 32 t€ | 30 t€ | 16 t€ |
| Raw materials and services | 66 t€ | -68 t€ | -64 t€ |
| Personnel expenses | 127 t€ | -159 t€ | -134 t€ |
| Other operating expenses | 79 t€ | -65 t€ | -48 t€ |
| Operating profit (loss) | 55 t€ | 105 t€ | 73 t€ |
| Financial income and expenses + (-) | 466 € | -264 € | 2 281 € |
| Profit (loss) before appropriations and taxes | 55 t€ | 105 t€ | 75 t€ |
| Income taxes | 11 t€ | -21 t€ | -15 t€ |
| Profit (loss) for the financial year | 44 t€ | 84 t€ | 60 t€ |
Balance sheet
| 31.10.2025 | 31.10.2024 | 31.10.2023 | |
|---|---|---|---|
| Non-current assets | 227 t€ | 199 t€ | 127 t€ |
| Receivables | 34 t€ | 65 t€ | 48 t€ |
| Cash in hand and at banks | 27 t€ | 14 t€ | 29 t€ |
| Current assets | 61 t€ | 78 t€ | 77 t€ |
| Assets | 287 t€ | 278 t€ | 204 t€ |
| Share capital or other similar capital | 2 500 € | 2 500 € | 2 500 € |
| Capital and reserves | 274 t€ | 250 t€ | 181 t€ |
| Short-term liabilities | 14 t€ | 27 t€ | 23 t€ |
| Liabilities | 14 t€ | 27 t€ | 23 t€ |
All financial statement items (41)
| 31.10.2025 | 31.10.2024 | 31.10.2023 | |
|---|---|---|---|
| Turnover | 296 t€ | 367 t€ | 304 t€ |
| Other operating income | 32 t€ | 30 t€ | 16 t€ |
| Raw materials and services | 66 t€ | -68 t€ | -64 t€ |
| Personnel expenses | 127 t€ | -159 t€ | -134 t€ |
| Other operating expenses | 79 t€ | -65 t€ | -48 t€ |
| Operating profit (loss) | 55 t€ | 105 t€ | 73 t€ |
| Financial income and expenses + (-) | 466 € | -264 € | 2 281 € |
| Profit (loss) before appropriations and taxes | 55 t€ | 105 t€ | 75 t€ |
| Income taxes | 11 t€ | -21 t€ | -15 t€ |
| Profit (loss) for the financial year | 44 t€ | 84 t€ | 60 t€ |
| Non-current assets | 227 t€ | 199 t€ | 127 t€ |
| Receivables | 34 t€ | 65 t€ | 48 t€ |
| Cash in hand and at banks | 27 t€ | 14 t€ | 29 t€ |
| Current assets | 61 t€ | 78 t€ | 77 t€ |
| Assets | 287 t€ | 278 t€ | 204 t€ |
| Share capital or other similar capital | 2 500 € | 2 500 € | 2 500 € |
| Capital and reserves | 274 t€ | 250 t€ | 181 t€ |
| Short-term liabilities | 14 t€ | 27 t€ | 23 t€ |
| Liabilities | 14 t€ | 27 t€ | 23 t€ |
| Investments | 227 t€ | 199 t€ | 127 t€ |
| Other short-term receivables | 3 733 € | 3 857 € | 2 557 € |
| Other current liabilities | 12 t€ | 16 t€ | 20 t€ |
| Retained earnings | 228 t€ | 164 t€ | 118 t€ |
| Long-term receivables | 0 € | 22 t€ | 22 t€ |
| Short-term prepayments and accrued income | 1 018 € | 8 264 € | 140 € |
| Short-term accounts payable | 0 € | 126 € | 0 € |
| Short-term sales receivables | 19 t€ | 19 t€ | 20 t€ |
| Profit (loss) for the period, equity | 44 t€ | 84 t€ | 60 t€ |
| Long-term loan receivables | 0 € | 22 t€ | 22 t€ |
| Short-term receivables | 34 t€ | 42 t€ | 26 t€ |
| Interest expenses and other financial expenses for non-Group companies | 1 202 € | -1 212 € | -278 € |
| Wages and salaries | 123 t€ | -152 t€ | -129 t€ |
| Short-term accrued expenses and deferred income | 1 335 € | 11 t€ | 3 721 € |
| Short-term loan receivables | 0 € | 2 000 € | 2 500 € |
| Current receivables from participating interests | 10 t€ | 9 433 € | 0 € |
| Liabilities | 287 t€ | 278 t€ | 204 t€ |
| Other interest and financial income from non-group companies | 736 € | 948 € | 2 559 € |
| Other social security expenses | 2 012 € | -1 843 € | -1 968 € |
| Services purchased | 66 t€ | -68 t€ | -64 t€ |
| Other shares and similar rights of ownership | 227 t€ | 199 t€ | 127 t€ |
| Pension expenses | 2 156 € | -5 092 € | -3 397 € |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, AK Medical Oy is in the upper half of the industry class medical specialists activities (2077 companies with taxable income; median 81 t€).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.